Home
>
National Drug Code (NDC)
>
Tikosyn
Tikosyn - 0069-5820-61 - (dofetilide)
Drug Information of Tikosyn
| Product NDC: | 0069-5820 |
| Proprietary Name: | Tikosyn |
| Non Proprietary Name: | dofetilide |
| Active Ingredient(s): | .5 mg/1 & nbsp; dofetilide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Tikosyn
| Product NDC: | 0069-5820 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020931 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19991001 |
Package Information of Tikosyn
| Package NDC: | 0069-5820-61 |
| Package Description: | 14 CAPSULE in 1 BOTTLE (0069-5820-61) |
NDC Information of Tikosyn
| NDC Code | 0069-5820-61 |
| Proprietary Name | Tikosyn |
| Package Description | 14 CAPSULE in 1 BOTTLE (0069-5820-61) |
| Product NDC | 0069-5820 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dofetilide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19991001 |
| Marketing Category Name | NDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Substance Name | DOFETILIDE |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Antiarrhythmic [EPC] |
